Effects of Sulfate-Rich Mineral Water on Functional Constipation: A Double-Blind, Randomized, Placebo-Controlled Study

被引:19
|
作者
Naumann, Johannes [1 ]
Sadaghiani, Catharina [1 ]
Alt, Felix [2 ]
Huber, Roman [3 ]
机构
[1] Univ Med Ctr Freiburg, Interdisciplinary Ctr Treatment & Res Balneol, Fac Med, Inst Environm Hlth Sci & Hosp Infect Control, Breisacher Str 115b, D-79106 Freiburg, Germany
[2] Analyze & Realize GmbH, Clin Res, Berlin, Germany
[3] Univ Med Ctr Freiburg, Fac Med, Ctr Complementary Med, Inst Environm Hlth Sci & Hosp Infect Control, Freiburg, Germany
来源
FORSCHENDE KOMPLEMENTARMEDIZIN | 2016年 / 23卷 / 06期
关键词
Functional constipation; Bowel movements; Mineral water; Sulfate; Magnesium; CARBONATED WATER; BICARBONATE; MAGNESIUM; HEALTH; VALIDATION; CALCIUM; FIBER; RISK;
D O I
10.1159/000449436
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Magnesium sulfate has a long tradition as a laxative. It osmotically prevents water absorption in the large bowel and thus leads to an acceleration of the intestinal transit and better stool consistency. We wanted to investigate the efficacy of a carbonated calcium/magnesium sulfate-rich natural mineral water in subjects with functional constipation (FC). Patients and Methods: In this double-blind, randomized, placebo-controlled study, subjects with FC (Rome III criteria) received 1 l/day (4 x 250 ml) of mineral water (Ensinger Schiller Quelle) or carbonated tap water (placebo) for 6 weeks. The primary endpoint was the change in the frequency of bowel movements per week between baseline and visit 4 (after 6 weeks). The prespecified main secondary endpoint was the change in the frequency of bowel movements per week between baseline and visit 3 (after 3 weeks). Results: Efficacy was analyzed in 100 subjects (intention-to-treat). After 6 weeks of treatment there was no statistical difference between the groups (p = 0.163). However, statistical significance was reached after 3 weeks, with an increase in the frequency of bowel movements per week of 2.02 +/- 2.22 for the mineral water group compared to 0.88 +/- 1.67 for the placebo group (p = 0.005). Conclusions: A 3-week treatment with 1 l/day of the sulfate-rich mineral water improved the frequency of bowel movements in subjects with FC compared with tap water; however, the difference was no longer significant after 6 weeks. Further evaluation in rigorously designed clinical studies will be necessary to validate the impact of sulfate-rich natural mineral water on FC. (C) 2016 S. Karger GmbH, Freiburg
引用
收藏
页码:356 / 363
页数:8
相关论文
共 50 条
  • [41] Effect of the probiotic strain, Lactiplantibacillus plantarum P9, on chronic constipation: A randomized, double-blind, placebo-controlled study
    Ma, Teng
    Yang, Ni
    Xie, Yong
    Li, Yingmeng
    Xiao, Qiuping
    Li, Qiong
    Jin, Hao
    Zheng, Longjin
    Sun, Zhihong
    Zuo, Kexuan
    Kwok, Lai-Yu
    Zhang, Heping
    Lu, Nonghua
    Liu, Wenjun
    PHARMACOLOGICAL RESEARCH, 2023, 191
  • [42] Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study
    Ke, M.
    Zou, D.
    Yuan, Y.
    Li, Y.
    Lin, L.
    Hao, J.
    Hou, X.
    Kim, H. J.
    NEUROGASTROENTEROLOGY AND MOTILITY, 2012, 24 (11) : 999 - e541
  • [43] An Extract of Glycyrrhiza glabra (GutGard) Alleviates Symptoms of Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Study
    Raveendra, Kadur Ramamurthy
    Jayachandra
    Srinivasa, Venkatappa
    Sushma, Kadur Raveendra
    Allan, Joseph Joshua
    Goudar, Krishnagouda Shankargouda
    Shivaprasad, Hebbani Nagarajappa
    Venkateshwarlu, Kudiganti
    Geetharani, Periasamy
    Sushma, Gopalakrishna
    Agarwal, Amit
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012 : 1 - 9
  • [44] Efficacy and Safety of the Cudrania tricuspidata Extract on Functional Dyspepsia: A Randomized Double-Blind Placebo-Controlled Multicenter Study
    Shin, Jinyoung
    Oh, Tae-Hoon
    Kim, Joo-Yun
    Shim, Jae-Jung
    Lee, Jung-Lyoul
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [45] Refined Deep Seawater Improves Serum Lipid Profile in Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial
    Kim, Min-Jee
    Lim, Chi-Yeon
    Lee, Kyu-Shik
    Nam, Kyung-Soo
    Kim, Hojun
    JOURNAL OF MEDICINAL FOOD, 2020, 23 (08) : 886 - 894
  • [46] Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    Hamano, Jun
    Higashibata, Takahiro
    Kessoku, Takaomi
    Kajiura, Shinya
    Hirakawa, Mami
    Oyamada, Shunsuke
    Ariyoshi, Keisuke
    Yamada, Takeshi
    Yamamoto, Yoshiyuki
    Takashima, Yasuyuki
    Doki, Kosuke
    Homma, Masato
    Mathis, Bryan J.
    Jono, Tsumugi
    Ogata, Tomoki
    Tanaka, Kosuke
    Kasai, Yuki
    Iwaki, Michihiro
    Fuyuki, Akiko
    Nakajima, Atsushi
    Hayashi, Ryuji
    Ando, Takayuki
    Izawa, Naoki
    Kobayashi, Yuko
    Horie, Yoshiki
    Morita, Tatsuya
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (35)
  • [47] Effect of Diamel in patients with metabolic syndrome: A randomized double-blind placebo-controlled study
    Cabrera-Rode, Eduardo
    Orlandi, Neraldo
    Padron, Yaneysi
    Arranz, Celeste
    Olano, Raysa
    Machado, Mayra
    Hernandez-Yero, Arturo
    Calderin, Raul
    Dominguez, Emma
    JOURNAL OF DIABETES, 2013, 5 (02) : 180 - 191
  • [48] A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
    Turner, R. Scott
    Thomas, Ronald G.
    Craft, Suzanne
    van Dyck, Christopher H.
    Mintzer, Jacobo
    Reynolds, Brigid A.
    Brewer, James B.
    Rissman, Robert A.
    Raman, Rema
    Aisen, Paul S.
    NEUROLOGY, 2015, 85 (16) : 1383 - 1391
  • [49] Efficacy and safety of vibrating capsule for functional constipation (VICONS): A randomised, double-blind, placebo-controlled, multicenter trial
    Zhu, Jia-Hui
    Qian, Yang-Yang
    Pan, Jun
    He, Chen
    Lan, Yu
    Chen, Wei-Na
    Wang, Bang-Mao
    Zhao, Wei
    Li, Jing-Nan
    Li, Xiao-Qing
    Lv, Bin
    Fan, Yi-Hong
    Zuo, Xiu-Li
    Li, Zhen
    Zou, Duo-Wu
    Li, Zhao-Shen
    Liao, Zhuan
    ECLINICALMEDICINE, 2022, 47
  • [50] A multicenter, double-blind, randomized, placebo-controlled study of rifaximin for the treatment of bacterial vaginosis
    Donders, Gilbert G. G.
    Guaschino, Secondo
    Peters, Klaus
    Tacchi, Raffaella
    Lauro, Vittoria
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2013, 120 (02) : 131 - 136